{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:15:48Z","timestamp":1785244548435,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,9,10]],"date-time":"2016-09-10T00:00:00Z","timestamp":1473465600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["15-30631A"],"award-info":[{"award-number":["15-30631A"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00432-016-2247-8","type":"journal-article","created":{"date-parts":[[2016,9,10]],"date-time":"2016-09-10T12:58:30Z","timestamp":1473512310000},"page":"2561-2567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cryopreserved NK cells in the treatment of haematological malignancies: preclinical study"],"prefix":"10.1007","volume":"142","author":[{"given":"Monika","family":"Holubova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Miklikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Leba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Georgiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Jindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Caprnda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachele","family":"Ciccocioppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kruzliak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lysak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,10]]},"reference":[{"key":"2247_CR1","first-page":"215","volume":"27","author":"M Bebenek","year":"2007","unstructured":"Bebenek M, Dus D, Kozlak J (2007) Fas\/Fas-ligand expressions in primary breast cancer are significant predictors of its skeletal spread. Anticancer Res 27:215\u2013218","journal-title":"Anticancer Res"},{"key":"2247_CR2","doi-asserted-by":"crossref","unstructured":"Biassoni R, Bottino C, Cantoni C, Moretta A (2002) Human natural killer receptors and their ligands. Curr Protoc Immunol Chapter 14:Unit 14.10","DOI":"10.1002\/0471142735.im1410s46"},{"key":"2247_CR3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","volume":"112","author":"MA Caligiuri","year":"2008","unstructured":"Caligiuri MA (2008) Human natural killer cells. Blood 112:461\u2013469","journal-title":"Blood"},{"key":"2247_CR4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2567.2010.03398.x","volume":"132","author":"KS Campbell","year":"2011","unstructured":"Campbell KS, Purdy AK (2011) Structure\/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations. Immunology 132:315\u2013325","journal-title":"Immunology"},{"key":"2247_CR5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.189.5.787","volume":"189","author":"C Cantoni","year":"1999","unstructured":"Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R, Malaspina A, Parolini S, Moretta L, Moretta A, Biassoni R (1999) NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med 189:787\u2013796","journal-title":"J Exp Med"},{"key":"2247_CR6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/cmi.2013.10","volume":"10","author":"M Cheng","year":"2013","unstructured":"Cheng M, Chen Y, Xiao W, Sun R, Tian Z (2013) NK cell-based immunotherapy for malignant diseases. Cell Mol Immunol 10:230\u2013252","journal-title":"Cell Mol Immunol"},{"key":"2247_CR7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1078\/0171-2985-00219","volume":"207","author":"J Clausen","year":"2003","unstructured":"Clausen J, Vergeiner B, Enk M, Petzer AL, Gastl G, Gunsilius E (2003) Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells. Immunobiology 207:85\u201393","journal-title":"Immunobiology"},{"key":"2247_CR8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","volume":"22","author":"MA Cooper","year":"2001","unstructured":"Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22:633\u2013640","journal-title":"Trends Immunol"},{"key":"2247_CR9","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1182\/blood.V99.10.3661","volume":"99","author":"RT Costello","year":"2002","unstructured":"Costello RT, Sivori S, Marcenaro E, Lafage-Pochitaloff M, Mozziconacci MJ, Reviron D, Gastaut JA, Pende D, Olive D, Moretta A (2002) Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 99:3661\u20133667","journal-title":"Blood"},{"key":"2247_CR10","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3390\/ph8020250","volume":"8","author":"CT Davis","year":"2015","unstructured":"Davis CT, Rizzieri D (2015) Immunotherapeutic applications of NK cells. Pharmaceuticals (Basel) 8:250\u2013256","journal-title":"Pharmaceuticals"},{"key":"2247_CR11","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1186\/ar2336","volume":"9","author":"C Rham de","year":"2007","unstructured":"de Rham C, Ferrari-Lacraz S, Jendly S, Schneiter G, Dayer JM, Villard J (2007) The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors. Arthritis Res Ther 9:R125","journal-title":"Arthritis Res Ther"},{"key":"2247_CR12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jim.2011.07.016","volume":"372","author":"BV Dons\u2019koi","year":"2011","unstructured":"Dons\u2019koi BV, Chernyshov VP, Osypchuk DV (2011) Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay. J Immunol Methods 372:187\u2013195","journal-title":"J Immunol Methods"},{"key":"2247_CR13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.seminhematol.2006.01.006","volume":"43","author":"SS Farag","year":"2006","unstructured":"Farag SS, Caligiuri MA (2006) Immunologic approaches to acute leukemia in the elderly. Semin Hematol 43:118\u2013125","journal-title":"Semin Hematol"},{"key":"2247_CR14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood-2005-08-027979","volume":"109","author":"C Fauriat","year":"2007","unstructured":"Fauriat C, Just-Landi S, Mallet F, Arnoulet C, Sainty D, Olive D, Costello RT (2007) Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction. Blood 109:323\u2013330","journal-title":"Blood"},{"key":"2247_CR15","first-page":"998","volume":"89","author":"F Ferrara","year":"2004","unstructured":"Ferrara F, Palmieri S, Mele G (2004) Prognostic factors and therapeutic options for relapsed or refractory acute myeloid leukemia. Haematologica 89:998\u20131008","journal-title":"Haematologica"},{"key":"2247_CR16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1471-2407-9-186","volume":"9","author":"T Garcia-Iglesias","year":"2009","unstructured":"Garcia-Iglesias T, Del Toro-Arreola A, Albarran-Somoza B, Del Toro-Arreola S, Sanchez-Hernandez PE, Ramirez-Due\u00f1as MG, Balderas-Pe\u00f1a LM, Bravo-Cuellar A, Ortiz-Lazareno PC, Daneri-Navarro A (2009) Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions. BMC Cancer 9:186","journal-title":"BMC Cancer"},{"key":"2247_CR17","doi-asserted-by":"crossref","first-page":"e108326","DOI":"10.1371\/journal.pone.0108326","volume":"9","author":"L Huergo-Zapico","year":"2014","unstructured":"Huergo-Zapico L, Acebes-Huerta A, Gonzalez-Rodriguez AP, Contesti J, Gonzalez-Garc\u00eda E, Payer AR, Villa-Alvarez M, Fern\u00e1ndez-Guiz\u00e1n A, L\u00f3pez-Soto A, Gonzalez S (2014) Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease. PLoS ONE 9:e108326","journal-title":"PLoS ONE"},{"key":"2247_CR18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1365-3083.2002.01053.x","volume":"55","author":"K Karre","year":"2002","unstructured":"Karre K (2002) NK cells, MHC class I molecules and the missing self. Scand J Immunol 55:221\u2013228","journal-title":"Scand J Immunol"},{"key":"2247_CR19","first-page":"646","volume":"88","author":"W Kern","year":"2003","unstructured":"Kern W, Danhauser-Riedl S, Ratei R, Schnittger S, Schoch C, Kolb HJ, Ludwig WD, Hiddemann W, Haferlach T (2003) Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow. Haematologica 88:646\u2013653","journal-title":"Haematologica"},{"issue":"231\u2013241","key":"2247_CR20","first-page":"e1","volume":"15","author":"EK Kim","year":"2013","unstructured":"Kim EK, Ahn YO, Kim S, Kim TM, Keam B, Heo DS (2013) Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers. Cytotherapy 15(231\u2013241):e1","journal-title":"Cytotherapy"},{"key":"2247_CR21","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.coi.2011.08.003","volume":"23","author":"W Liao","year":"2011","unstructured":"Liao W, Lin JX, Leonard WJ (2011) IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol 23:598\u2013604","journal-title":"Curr Opin Immunol"},{"key":"2247_CR22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/15258160260194794","volume":"11","author":"J Luhm","year":"2002","unstructured":"Luhm J, Brand JM, Koritke P, Hoppner M, Kirchner H, Frohn C (2002) Large-scale generation of natural killer lymphocytes for clinical application. J Hematother Stem Cell Res 11:651\u2013657","journal-title":"J Hematother Stem Cell Res"},{"key":"2247_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jlb.48.2.163","volume":"48","author":"RJ Melder","year":"1990","unstructured":"Melder RJ, Walker ER, Herberman RB, Whiteside TL (1990) Surface characteristics, morphology, and ultrastructure of human adherent lymphokine-activated killer cells. J Leukoc Biol 48:163\u2013173","journal-title":"J Leukoc Biol"},{"key":"2247_CR24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/sj.emboj.7600019","volume":"23","author":"L Moretta","year":"2004","unstructured":"Moretta L, Moretta A (2004) Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 23:255\u2013259","journal-title":"EMBO J"},{"key":"2247_CR25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/intimm\/10.6.719","volume":"10","author":"L Rodella","year":"1998","unstructured":"Rodella L, Rezzani R, Zauli G, Mariani AR, Rizzoli R, Vitale M (1998) Apoptosis induced by NK cells is modulated by the NK-active cytokines IL-2 and IL-12. Int Immunol 10:719\u2013725","journal-title":"Int Immunol"},{"key":"2247_CR26","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1365-2141.2001.03055.x","volume":"115","author":"L Rodella","year":"2001","unstructured":"Rodella L, Zamai L, Rezzani R, Artico M, Peri G, Falconi M, Facchini A, Pelusi G, Vitale M (2001) Interleukin 2 and interleukin 15 differentially predispose natural killer cells to apoptosis mediated by endothelial and tumour cells. Br J Haematol 115:442\u2013450","journal-title":"Br J Haematol"},{"key":"2247_CR27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood-2006-07-038687","volume":"110","author":"L Ruggeri","year":"2007","unstructured":"Ruggeri L, Mancusi A, Capanni M, Urbani E, Carotti A, Aloisi T, Stern M, Pende D, Perruccio K, Burchielli E, Topini F, Bianchi E, Aversa F, Martelli MF, Velardi A (2007) Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood 110:433\u2013440","journal-title":"Blood"},{"key":"2247_CR28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10120-011-0059-8","volume":"15","author":"H Saito","year":"2012","unstructured":"Saito H, Osaki T, Ikeguchi M (2012) Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer. Gastric Cancer 15:27\u201333","journal-title":"Gastric Cancer"},{"key":"2247_CR29","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.4049\/jimmunol.169.8.4098","volume":"169","author":"HR Salih","year":"2002","unstructured":"Salih HR, Rammensee HG, Steinle A (2002) Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J Immunol 169:4098\u20134102","journal-title":"J Immunol"},{"key":"2247_CR30","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1182\/blood-2003-03-0880","volume":"102","author":"S Schnittger","year":"2003","unstructured":"Schnittger S, Weisser M, Schoch C, Hiddemann W, Haferlach T, Kern W (2003) New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcripts. Blood 102:2746\u20132755","journal-title":"Blood"},{"key":"2247_CR31","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nri911","volume":"2","author":"JA Trapani","year":"2002","unstructured":"Trapani JA, Smyth MJ (2002) Functional significance of the perforin\/granzyme cell death pathway. Nat Rev Immunol 2:735\u2013747","journal-title":"Nat Rev Immunol"},{"key":"2247_CR32","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1084\/jem.187.12.2065","volume":"187","author":"M Vitale","year":"1998","unstructured":"Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, Marcenaro E, Augugliaro R, Moretta L, Moretta A (1998) NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 187:2065\u20132072","journal-title":"J Exp Med"},{"key":"2247_CR33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/cimm.1993.1227","volume":"151","author":"NL Vujanovic","year":"1993","unstructured":"Vujanovic NL, Rabinowich H, Lee YJ, Jost L, Herberman RB, Whiteside TL (1993) Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic. Cell Immunol 151:133\u2013157","journal-title":"Cell Immunol"},{"key":"2247_CR34","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1038\/onc.2008.267","volume":"27","author":"I Waldhauer","year":"2008","unstructured":"Waldhauer I, Steinle A (2008) NK cells and cancer immunosurveillance. Oncogene 27:5932\u20135943","journal-title":"Oncogene"},{"key":"2247_CR35","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/eji.200324070","volume":"33","author":"RP Wallin","year":"2003","unstructured":"Wallin RP, Screpanti V, Michaelsson J, Grandien A, Ljunggren HG (2003) Regulation of perforin-independent NK cell-mediated cytotoxicity. Eur J Immunol 33:2727\u20132735","journal-title":"Eur J Immunol"},{"key":"2247_CR36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20051884","volume":"203","author":"M Yawata","year":"2006","unstructured":"Yawata M, Yawata N, Draghi M, Little AM, Partheniou F, Parham P (2006) Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 203:633\u2013645","journal-title":"J Exp Med"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-016-2247-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-016-2247-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-016-2247-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T06:46:24Z","timestamp":1568357184000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-016-2247-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,10]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2247"],"URL":"https:\/\/doi.org\/10.1007\/s00432-016-2247-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,10]]}}}